SlideShare a Scribd company logo
1 of 110
K A T H L E E N A . B R A D Y , M D
M E D I C A L D I R E C T O R / M E D I C A L
E P I D E M I O L O G I S T
A I D S A C T I V I T I E S C O O R D I N A T I N G O F F I C E
J A N U A R Y 9 , 2 0 1 3
The HIV Engagement in Care
Cascade
The Gardner Cascade
Engagement in Care
Gardner Stage of Engagement in HIV Care
Gardner Stage of Engagement in HIV Care
19%
undetectable
National and Local Engagement in Care
 Data
 National and local HIV Surveillance System
 Prevalence (total, diagnosed) – number of persons living with HIV
 Linkage to care
 Medical Monitoring Project (MMP)
 Retention in care
 Prescribed ART
 Viral suppression
Methods
 Prevalence
 HIV diagnosis data
 Data adjustments at the national level
 Back-calculation methods to estimate unaware
 Linkage to Care
 Data reported through December 2011
 Percentage of persons with >1 CD4 or viral load test result
within 3 months of HIV diagnosis
Medical Monitoring Project
 MMP is a national probability sample of HIV-infected
persons receiving care in the US in order to:
 describe HIV care and support services being received and the
quality of such services
 describe the prevalence and occurrence of co-morbidities related to
HIV disease
 determine prevalence of ongoing risk behaviors and access to and
use of prevention services among persons living with HIV
 identify met and unmet needs for HIV care and prevention services
in order to inform community and care planning groups, health care
providers and other stakeholders
 Philadelphia has participated in MMP since 2005. All
charts of sampled patients are abstracted for clinical
information and patients are offered a voluntary
interview.
MMP Population Size Estimates
 States, facilities, and patients sampled with known
probabilities
 Analysis weights include:
 Design weights
 Inverse of the probability of selection
 Extend inference from sample to reference population
 Non-response adjustment
 Extend inference from respondents to sample
 Sum of weights estimates number of HIV-infected
adults who received at least one medical visit
January-April 2009
MMP Definitions
 Retention in care: Number of HIV-infected adults
who received at least one medical care visit between
January and April 2009
 Prescription of antiretroviral therapy (ART):
Documentation in medical record abstraction of any
ART prescription in the past 12 months
 Viral suppression: Documentation in medical
record abstraction of most
Philadelphia Engagement in Care, 2009
19188
100% 15753
82% 11894
62% 9944
52%
8751
46% 5775
30%
0
5000
10000
15000
20000
25000
For every 100 people living with HIV:
US
Number
82
Are aware of their
infection
66 Are linked to HIV care
37 Stay in HIV care
33
Get antiretroviral
therapy
25
Have a very low amount
of virus in their body
Philadelphia
Number
82
Are aware of their
infection
62 Are linked to HIV care
52 Stay in HIV care
46
Get antiretroviral
therapy
30
Have a very low amount
of virus in their body
2009 Data
Who is Aware?
Philadelphia Engagement in Care, 2009
19188
100% 15753
82% 11894
62% 9944
52%
8751
46% 5775
30%
0
5000
10000
15000
20000
25000
HIV Prevalence in Philadelphia
(reported thru 6/30/2012)
 19,157 PLWHA (aware)
 11,583 AIDS cases
 7,574 HIV cases
 5,092 estimated to be
living with HIV and
unaware
 1.59% Philadelphia
residents estimated to be
HIV+
 Rates (known) vary by
race
 2.1% of blacks
 1.5% of Latinos
 0.7% of whites
 Rates vary by sex
 1.9% of males
 0.7% of females
19
HIV/AIDS Cases by Date of Diagnosis
1178
1302
1177
1001
898
1200
894 895 907
861 821
712 756
652
452
221 239
176
940 918 921 893
729 712
1308
0
200
400
600
800
1000
1200
1400
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
Year
NumberofCases
AIDS HIV
20
HIV/AIDS Cases by Sex and Date of
Diagnosis
0
200
400
600
800
1000
1200
1400
1600
1991
1993
1995
1997
1999
2001
2003
2005
2007
2009
2011
Year
NumberofCases
AIDS Female AIDS Male HIV Female HIV Male
21
HIV Cases by Race/Ethnicity and Date of
Diagnosis
171
142 127
106 110
575 594
534
479 498
133 146
210
127
95
0
100
200
300
400
500
600
700
2006 2007 2008 2009 2010 2011
Year
NumberofCases
White AfrAm Hispanic
HIV diagnoses by risk group, 2007-2011
0
100
200
300
400
500
600
2007 2008 2009 2010 2011
MSM IDU HET
Demographics of new positives, MSM
New HIV diagnoses among
MSM by race, 2007-2011
0%
10%
20%
30%
40%
50%
60%
70%
Black Latino White
New HIV diagnoses among
MSM by age, 2007-2011
0%
10%
20%
30%
40%
50%
60%
13 - 24 25 - 44 45+
New HIV diagnoses among
MSM youth, 2007-2011
New HIV diagnoses among
MSM youth, 2007-2011
75.4%
9.3%
12.6%
Race
Black White Latino
7.6%
92.0%
Age
13-17 18-24
Demographics of new positives, MSM youth
New HIV diagnoses among
IDU, 2007-2011
New HIV diagnoses among
IDU, 2007-2011
44.1%
38.0%
16.0%
Race
Black White Latino
10.2%
53.1%
36.2%
Age
13-24 25-44 45+
Demographics of new positives, IDU
Demographics of new positives, IDU
2007 - 2011
70.1%
29.8%
Sex
Male
Female
New HIV diagnoses among
HET, 2007-2011
New HIV diagnoses among
HET, 2007-2011
72.7%
15.0%
8.8%
Race
Black White Latino
3.8%
50.6%
34.6%
Age
13-24 25-44 45+
Demographics of new positives, Heterosexuals
Demographics of new positives, HET
2007 - 2011
50.7%
49.2%
Sex
Male
Female
35
Summary
 High HIV morbidity in Philadelphia
 Philadelphia epidemic predominantly affects
minority populations
 MSM and Heterosexual transmission
predominant modes of transmission
 Cases among MSM are increasing
 Growing numbers of persons living with HIV
and AIDS
 25% decline in newly diagnosed AIDS
Who is getting infected?
Philadelphia Engagement in Care, 2009
19188
100% 15753
82% 11894
62% 9944
52%
8751
46% 5775
30%
0
5000
10000
15000
20000
25000
Incidence Surveillance
 Collect and STARHS test the diagnostic blood
specimens from all newly diagnosed HIV infections
reported from public and private laboratories and
providers to HIV Surveillance Unit.
 Collect the HIV testing information needed for the
statistical estimates of incidence.
 Calculate population-based estimates of HIV
incidence.
 Use these estimates to identify emerging sub-
epidemics, monitor trends, target prevention
resources and interventions to areas and
populations most heavily affected, and evaluate
programs.
Incidence vs. Prevalence
HIV Prevalence = the total number of HIV cases that exist at a
specific time within a specific population.
HIV Incidence = the number of individuals newly infected
with HIV within a given period of time (6 - 12
months).
20061981 2007
20061981 2007
Serologic
Testing
Algorithm for
Recent
HIV
Seroconversion
What is STARHS?
Remnant HIV+
Serum
Supplemental Data
STARHS
Testing
using BED
Assay
Includes:
•Race, sex, mode of
transmission
•Testing history &
reasons for testing
(Calculating weights)
•Any exclusionary
info (AIDS diagnosis,
prior recent ART)
•Adjust for LFU, QNS
HIV Incidence Estimation
Requirements for HIV Incidence
Surveillance
CDC STARHS Test Results
 (+) standard test and (+) STARHS test
= long-standing HIV infection
 (+) standard test and (-) STARHS test =
recent HIV infection
National Incidence Data, 2010
 Estimated 47,500 HIV infections in 2009 in adults
and adolescents (95% CI, 42,000 – 53,000)
 Estimated incidence 18.8 infections per 100,000 population
 44% among blacks, 21% Latinos
 63% among MSM, 25% heterosexual
 26% among 13-24 year olds
 Early signs of an encouraging decrease in new HIV
infections among black women
 21 percent decrease between 2008 and 2010
 Continuing increase in new infections among young
gay and bisexual men
 22 percent increase between 2008 and 2010
2010 Local Estimate of
HIV Incidence
 Local estimate of 577 new HIV infections in 2010 in
adults and adolescents (95% CI, 385-769)
 2010 estimate is significantly lower than the
estimate from 2008 (926 infections) and 2009
(945 infections)
 Case rate of 45.1 infections per 100,000 population
(2.4 times that of the national rate)
 The estimated decline in incidence must be
interpreted with caution due to violations in the
estimation assumptions
HIV Incidence Trends by Demographic Groups
0
200
400
600
800
1000
2006 2007 2008 2009 2010
Total
Age 13-24
Male
Black
MSM
HIV Incidence Trends by Demographic Groups
0
200
400
600
800
1000
2006 2010
Total
Age 13-24
Male
Black
MSM
Estimated Incidence Rates - 2010
Population Population in
2010 (13 +)
ESTIMATED
Incidence
Estimate,
20010
Estimated
Case Rate
per
100,000
95% CI
lower
bound
95% CI
upper
bound
MSM 29,737 306 1,029.0 578.4 1,483.0
IDU 37,378 44 117.7 0.0 254.2
HET 294,682 226 76.7 30.1 60.1
*Includes persons >13 living in poverty
Data Source: PDPH/AACO HIV Incidence Surveillance Program
Incidence Summary
 Includes people unaware of their status.
 40% decrease between 2009 and 2010
 P<0.05
 Declines in all demographic groups
 Incidence higher than baseline 2006 data for MSM
and youth 13-24
Who is unaware?
Philadelphia Engagement in Care, 2009
19188
100% 15753
82% 11894
62% 9944
52%
8751
46% 5775
30%
0
5000
10000
15000
20000
25000
Concurrent HIV/AIDS, 2010
Concurrent HIV/AIDS, 2010
National HIV Behavioral Surveillance
 Risk Behaviors
 Assess prevalence of and trends in risk behaviors
 Sexual risk behaviors
 Drug-use risk behaviors
 HIV Testing Behaviors
 Assess prevalence of and trends in HIV testing behaviors (not
included until HET-1)
NHBS Objectives (cont.)
 Prevention
 Assess exposure to and use of prevention services
 Assess impact of prevention services on behavior
 Identify prevention service gaps and missed opportunities for
prevention
NHBS-MSM3
 Interviews conducted at venues where at least 50%
of men identified as MSM
 List of venues included in your attachments
 566 MSM interviewed in Philadelphia
 545 had sex with a man in the last 12 months
 26.2% white, 57.6% black, 11.4% Latino
 83.6% identified as gay, 14.6% bisexual, 1.9% as straight
NHBS-MSM Summary
 We are not currently meeting the PHS guidelines for
HIV testing
 76.8% of MSM ever tested
 Less than half (46.9%) of MSM had tested in the last year
 Lower prevalence of HIV in MSM seen in
Philadelphia
Philadelphia NHBS-MSM3, 2011
76.4% 76.2% 76.1%
78.5%
NHBS-MSM3
% of MSM who had an
HIV test in the last 12
months
ALL MSM Black MSM
LatinoMSM White MSM
Demograp
hic Group
MSM3
% HIV
Positive
Tested =
519
MSM3
% New
Positiv
es
Total 11.9% 29.0%
Race
Black 14.9% 31.8%
White 8.5% 16.7%
Latino 6.8% 50.0%
Age
18-24 8.2% 50.0%
25-44 10.6% 35.1%
45+ 19.8% 21.1%
NHBS-IDU2
 539 IDU interviewed in Philadelphia
 75.3% male, 24.7% female, 88.1% over 30
 54.8% black, 42.8% white, 15% Latino
 87.8% reported ever testing for HIV with 2.8% reporting
being HIV+
 38.6% reported having an HIV test within the last year
 16.0% reported having an HIV test within the last 6
months
 57.7% ever tested for Hepatitis C
 52.1% told they had Hepatitis (95.0% Hep C)
IDU2 Testing Data
Demographic
Group
IDU2
% HIV Positive
(Tested = 536)
IDU2
% New
Positives
Total 8.9% 68.1%
Gender
Male 7.7% 70.0%
Female 12.9% 64.7%
Race
Black 14.3% 65.7%
White 2.6% 80.0%
Latino 8.6% 71.4%
IDU2 Testing Data
Demographic
Group
IDU2
% HIV Positive
(Tested = 536)
IDU2
% New
Positives
Age Group
18-24 0.0% 0.0%
25-44 3.8% 66.7%
45+ 13.5% 60.5%
Geographic Area
Kensington 4.2% 66.6%
NW 12.5% 100.0%
North 8.6% 76.9%
West 23.4% 55.5%
What is a High-Risk Heterosexual?
 Past definitions
 Multiple sexual partners
 Sexual partners’ risks
 New definitions evaluated in NHBS-HET1
 Geography (HIV is clustered in high-poverty
neighborhoods)
 Social networks (Some social and sexual networks have
high HIV despite equal individual risks, greater inter-
network mixing)
HIV Prevalence
NHBS-HET1 2006-2007
HIV Test Result
Negative
Positive
Total
14,543
294
14,837
N
(98)
(2)
(100)
(%)
2% HIV prevalence is 10 to 20 times greater
than that among all heterosexuals in the U.S.
10−19% 20−29% ≥ 40%
Proportion of Census Tract Residents Living Below the Poverty Level
0−9%
PercentHIV-positive
30−39%
HIV Prevalence, by Census Tract Poverty
NHBS-HET1 2006-2007
Chi-Square Trend, p< 0.0001
10−19,999 20−49,999 ≥ 50,000
Annual Household Income (in Dollars)
0−9,999
PercentHIV-positive HIV Prevalence, by Income
NHBS-HET1 2006-2007
Chi-Square Trend, p< 0.0001
10−19,999 20−49,999 ≥ 50,000
Annual Household Income (in Dollars)
0−9,999
PercentHIV-positive HIV Prevalence, by Income
NHBS-HET1 2006-2007
10−19,999 20−49,999 ≥ 50,000
Annual Household Income (in Dollars)
0−9,999
PercentHIV-positive HIV Prevalence, by Income
NHBS-HET1 2006-2007
6X Greater
*Controlling for city, sex, race/ethnicity, age, education, employment,
income, homeless status, crack use, exchange sex, and STD diagnosis.
HIV Prevalence, Multivariable Model*
NHBS-HET1 2006-2007
Low socioeconomic status was
associated with higher HIV prevalence:
• Low income
• Limited education
• Unemployment
• Resident of city
• Sex with an opposite-gender partner in the past year
• English- or Spanish-speaking
HIV Surveillance & Census Data
37 States with HIV Reporting 2007
Persons(inthousands)
Heterosexuals Living with HIV
African-
American
Latino White
HIV Surveillance & Census Data
37 States with HIV Reporting 2007
Persons(inthousands)
Heterosexuals Living with HIV
African-
American
Latino White
Persons(inmillions)
Adult & Adolescent Population
African-
American
Latino White
Ratio of Heterosexuals Living
with HIV to the Population–
African-Americans:
> 20 times greater
Latinos:
6 times greater
HIV Prevalence, by Race/Ethnicity
NHBS-HET1 2006-2007
African-
American
Latino White
PercentHIV-positive
p= 0.14
HIV Prevalence, by Race/Ethnicity
NHBS-HET1 2006-2007
All Census Tracts
African-
American
Latino White
PercentHIV-positive
African-
American
Latino White
High Poverty Census Tracts
PercentHIV-positive
p= 0.14
p= 0.73
HIV Prevalence, by Race/Ethnicity
NHBS-HET1 2006-2007
All Census Tracts
African-
American
Latino White
PercentHIV-positive
African-
American
Latino White
High Poverty Census Tracts
PercentHIV-positive
p= 0.14
p= 0.73
HIV Prevalence, by Race/Ethnicity
NHBS-HET1 2006-2007
All Census Tracts
African-
American
Latino White
PercentHIV-positive
African-
American
Latino White
High Poverty Census Tracts
PercentHIV-positive
p= 0.14
p= 0.73
Exchange
Sex
STD
Diagnosis
Crack
Use
PercentHIV-positive
Yes No
HIV Prevalence, by Risk Behavior
NHBS-HET1 2006-2007
p< 0.0001 p< 0.0001p< 0.0001
● HIV prevalence was very high
● Low socioeconomic status was
associated with higher HIV prevalence
● Racial and ethnic disparities in HIV
prevalence were substantially less than
those in the general population
● Crack use and exchange sex were not
associated with higher HIV prevalence
Summary
NHBS-HET2 Methods
 RDS method chosen for NHBS-HET2
 Eligibility Criteria
 Between the ages of 18-60
 Male or female
 Had vaginal or anal sex with a person of the opposite-sex in
the past 12 months
 Lives in the EMA
 Able to complete the interview in English or Spanish
NHBS-HET2 Data
 617 HET screened in Philadelphia
 552 HET interviewed
 510 met the HET definition
 42.5% male, 57.5% female
 25.3% 18-24
 84.3% black, 2.2% white, 12.4% Latino, 1.2% other
 94.9% had never injected drugs, 5.1% past IDU
 15.9% currently or previously homeless
NHBS-HET2 data
 Education
 34.5% less than high school education
 54.5% high school education
 10.0% with vocational/tech or some college
 1.0% college graduate
 Poverty
 10.6% above poverty guideline
 87.6% at or below poverty
HET2 Demographics
 HIV Testing
 76.3% reported ever testing for HIV with 2.8% reporting being
HIV+
 20.3% reported having an HIV test within the last 6 months
 28.4% reported having an HIV test within the last year
HET2 Testing Data
Tested # HIV Positive % New Positive
All Participants 4.4% (N=24) 79.2%
Low SES 4.5% (N=23)
Not Low SES 2.8% (N=1)
Male 5.9% (N=13)
Female 3.4% (N=10)
Black 5.1% (N=22)
Latino 1.6% (N=1)
White 0.0% (N=0)
HET2 Testing Data
Demographic
Group
HET2
% HIV Positive
(Tested = 552)
HET2
% New
Positives
All Participants 4.3% 79.2%
Gender
Male 5.4% 84.6%
Female 3.6% 72.7%
Race/Ethnicity
Black 5.0% 78.3%
Latino 1.4% 100.0%
White 0.0% 0.0%
HET2 Testing Data
Demographic
Group
HET2
% HIV Positive
(Tested = 552)
HET2
% New
Positives
Age
18-24 1.5% 50.0%
25-44 3.5% 75.0%
45+ 7.4% 85.7%
Low SES 3.4% 84.2%
Not Low SES 0.9% 60.0%
Linkage to care
Philadelphia Engagement in Care, 2009
19188
100% 15753
82% 11894
62% 9944
52%
8751
46% 5775
30%
0
5000
10000
15000
20000
25000
Linkage to Care 2009-2010
by Age, Race
74%
68%
73%
79%
75%
76%
72%
76%
81%
60%
65%
70%
75%
80%
85%
Total 13-24 25-34 35-44 45-54 55+ Black Hispanic White
Linkage to Care 2009-2010
by Sex, Mode
74%
68%
73% 72%
74% 75%
43%
69%
81%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Total Male Female MSM Male IDU Male HET Male
MSM/IDU
Female IDU Female HET
Retention in care
Philadelphia Engagement in Care, 2009
19188
100% 15753
82% 11894
62% 9944
52%
8751
46% 5775
30%
0
5000
10000
15000
20000
25000
Definition: Met Need for Primary Care
 Met Need for Primary Care defined as measurement
of at least one CD4 count and/or one Viral Load
and/or receipt of antiretroviral therapy during a
specified time period
Framework
 Input
 Population sizes of those with HIV and AIDS within the service
area
 Care Patterns of those with HIV and AIDS
 Calculated Result
 Number of persons with HIV and AIDS with unmet need
Population Sizes Value Data Source(s)
Row A. Number of persons living
with AIDS (PLWA), for
the period of
12/31/2011
11,569 Local HARS data
Row B. Number of persons living
with HIV (PLWH)/non-
AIDS/aware, for the
period of 12/31/2011
7,523 Local HARS data
Row C. Total number of
HIV+/aware for the
period of 12/31/2011
19,092 Local HARS data
Population Sizes
Care Patterns Value Data Source(s)
Row D. Number of PLWA
who received the
specified HIV
primary medical
care during the 12-
month period of
2011
9,948 Surveillance Data
(Lab Data)
CAREWare
Row E. Number of
PLWH/non-AIDS
who received the
specified HIV
primary medical
care during the 12-
month period of
2011
5,132 Surveillance Data
(Lab Data)
CAREWare
Row F. Total number of
HIV+/aware who
received the
specified HIV primary
medical care during
the 12-month period
of 2011
15,080
Calculated Results Value Calculation
Row G. Number of PLWA who
did not receive primary
medical services during
the 12-month period of
2011
1,621
(14.0%)
= A – D
Row H. Number of PLWH/non-
AIDS who did not receive
primary medical services
during the 12-month
period of 2011
2,391
(31.8%)
= B – E
Row I. Total of HIV+/aware not
receiving specified
primary medical care
services (quantified
estimate of unmet need
4,012
(21.0%)
= G + H
Unmet need by demographic groups, 2011
33.6%
13.4%
27.4%
15.5%
31.8%
15.2%
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
35.0%
40.0%
HIV AIDS
Black White Hispanic
33.4%
15.2%
28.1%
10.6%
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
35.0%
40.0%
HIV AIDS
Male Female
Unmet need by insurance status, 2011
28.3%
13.5%
22.4%
12.6%
33.7%
7.5%
46.4%
29.6%
43.1%
26.6%
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
35.0%
40.0%
45.0%
50.0%
HIV AIDS
Medicaid Private Other public Unknown None
Disparities
Philadelphia Engagement in Care, 2009
19188
100% 15753
82% 11894
62% 9944
52%
8751
46% 5775
30%
0
5000
10000
15000
20000
25000
Engagement in Care by Sex, 2009
0
2000
4000
6000
8000
10000
12000
Male
0
1000
2000
3000
4000
5000
6000
Female
Engagement in Care by Race/Ethnicity, 2009
0
2000
4000
6000
8000
10000
12000
Diagnosed In Care On ART Suppressed
Black White Hispanic
Engagement in Care by Mode of Transmission,
2009
0
1000
2000
3000
4000
5000
6000
Diagnosed In Care On ART Suppressed
MSM HET male HET female
Engagement in Care by Age Group, 2009
0
1000
2000
3000
4000
5000
6000
Diagnosed In Care On ART Suppressed
18-24 25-34 35-44 45-54 55+
Engagement in Care Summary
 On ART
 Higher for males than females
 Higher for men who have sex with men (MSM) than for
women who have sex with men (WSM)
 Viral suppression
 Higher for males than females
 Higher for MSM than WSM
 Higher for whites compared to blacks and Hispanics
 Higher for those >50 compared to 18-29 year olds
All P values <0.05
clinicaloptions.com/hiv
Starting Antiretroviral Therapy in 2012: A Compendium of Interactive Cases
What Will It Take to Substantially Reduce
HIV Transmission in an Entire Population?
•Answer: Treatment AND Prevention
•Gardner EM, et al. Clin Infect Dis. 2011;52:793-800.
•200,000
•600,000
•0
•800,000
•1,000,000
•1,200,000
•400,000
•19% •22%
•34% •28% •21%
•66%
•NumberofIndividuals
•Current •DX
90%
•Engage
90%
•Treat
90%
•VL < 50
in 90%
•Dx,
Engage, Tx,
and VL < 50
in 90%
Undiagnosed HIV
Not linked to care
Not retained in care
ART not required
ART not utilized
Viremic on ART
Undetectable
HIV-1 RNA
Q U E S T I O N S ?
The End

More Related Content

What's hot

Regional slides-jun-2014
Regional slides-jun-2014Regional slides-jun-2014
Regional slides-jun-2014aidsdatahub
 
Getting to scale: How we can achieve the reach required of prevention service...
Getting to scale: How we can achieve the reach required of prevention service...Getting to scale: How we can achieve the reach required of prevention service...
Getting to scale: How we can achieve the reach required of prevention service...HopkinsCFAR
 
Facing the Future of HIV and STD in Texas Epidemiology, Impact, and Priorities
Facing the Future of HIV and STD in Texas Epidemiology, Impact, and PrioritiesFacing the Future of HIV and STD in Texas Epidemiology, Impact, and Priorities
Facing the Future of HIV and STD in Texas Epidemiology, Impact, and PrioritiesDSHS
 
Texas HIV/STD Conference: Greater Than AIDS
Texas HIV/STD Conference: Greater Than AIDSTexas HIV/STD Conference: Greater Than AIDS
Texas HIV/STD Conference: Greater Than AIDSkcaluko
 
2007 aids epidemic update
2007 aids epidemic update2007 aids epidemic update
2007 aids epidemic updatePim Piepers
 
Regional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve KrausRegional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve KrausDr. Rubz
 
Health disparities plenary (4)
Health disparities plenary (4)Health disparities plenary (4)
Health disparities plenary (4)CDC NPIN
 
HIV/AIDS data Hub Asia Pacific -Malaysia 2014
HIV/AIDS data Hub Asia Pacific -Malaysia  2014HIV/AIDS data Hub Asia Pacific -Malaysia  2014
HIV/AIDS data Hub Asia Pacific -Malaysia 2014Dr. Rubz
 
Test and Treat: The Gardner Cascade in Context
Test and Treat:  The Gardner Cascade in ContextTest and Treat:  The Gardner Cascade in Context
Test and Treat: The Gardner Cascade in ContextOffice of HIV Planning
 
Lymphatic Filariasis Winnable Battle presentation
Lymphatic Filariasis Winnable Battle presentationLymphatic Filariasis Winnable Battle presentation
Lymphatic Filariasis Winnable Battle presentationPublicHealthFoundation
 
Epidemiological Update 2017 (Positive Committee)
Epidemiological Update 2017 (Positive Committee)Epidemiological Update 2017 (Positive Committee)
Epidemiological Update 2017 (Positive Committee)Office of HIV Planning
 

What's hot (19)

B.1 hiv-in-india
B.1 hiv-in-indiaB.1 hiv-in-india
B.1 hiv-in-india
 
Regional slides-jun-2014
Regional slides-jun-2014Regional slides-jun-2014
Regional slides-jun-2014
 
PrEP in 2018 and Beyond
PrEP in 2018 and BeyondPrEP in 2018 and Beyond
PrEP in 2018 and Beyond
 
Scientific Sessions 2015: Global and sri lankan hiv situation among msm
Scientific Sessions 2015: Global and sri lankan hiv situation among msmScientific Sessions 2015: Global and sri lankan hiv situation among msm
Scientific Sessions 2015: Global and sri lankan hiv situation among msm
 
Getting to scale: How we can achieve the reach required of prevention service...
Getting to scale: How we can achieve the reach required of prevention service...Getting to scale: How we can achieve the reach required of prevention service...
Getting to scale: How we can achieve the reach required of prevention service...
 
Facing the Future of HIV and STD in Texas Epidemiology, Impact, and Priorities
Facing the Future of HIV and STD in Texas Epidemiology, Impact, and PrioritiesFacing the Future of HIV and STD in Texas Epidemiology, Impact, and Priorities
Facing the Future of HIV and STD in Texas Epidemiology, Impact, and Priorities
 
Importance and implication of starting HIV treatment early
Importance and implication of starting HIV treatment earlyImportance and implication of starting HIV treatment early
Importance and implication of starting HIV treatment early
 
Texas HIV/STD Conference: Greater Than AIDS
Texas HIV/STD Conference: Greater Than AIDSTexas HIV/STD Conference: Greater Than AIDS
Texas HIV/STD Conference: Greater Than AIDS
 
HIV Winnable Battle presentation
HIV Winnable Battle presentationHIV Winnable Battle presentation
HIV Winnable Battle presentation
 
HIV among migrants, what do we know?
HIV among migrants, what do we know?HIV among migrants, what do we know?
HIV among migrants, what do we know?
 
Barriers of HIV Prevention through Treatment
Barriers of HIV Prevention through TreatmentBarriers of HIV Prevention through Treatment
Barriers of HIV Prevention through Treatment
 
2007 aids epidemic update
2007 aids epidemic update2007 aids epidemic update
2007 aids epidemic update
 
Regional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve KrausRegional Overview in HIV by Steve Kraus
Regional Overview in HIV by Steve Kraus
 
Health disparities plenary (4)
Health disparities plenary (4)Health disparities plenary (4)
Health disparities plenary (4)
 
HIV/AIDS data Hub Asia Pacific -Malaysia 2014
HIV/AIDS data Hub Asia Pacific -Malaysia  2014HIV/AIDS data Hub Asia Pacific -Malaysia  2014
HIV/AIDS data Hub Asia Pacific -Malaysia 2014
 
Test and Treat: The Gardner Cascade in Context
Test and Treat:  The Gardner Cascade in ContextTest and Treat:  The Gardner Cascade in Context
Test and Treat: The Gardner Cascade in Context
 
Lymphatic Filariasis Winnable Battle presentation
Lymphatic Filariasis Winnable Battle presentationLymphatic Filariasis Winnable Battle presentation
Lymphatic Filariasis Winnable Battle presentation
 
Epidemiological Update 2017 (Positive Committee)
Epidemiological Update 2017 (Positive Committee)Epidemiological Update 2017 (Positive Committee)
Epidemiological Update 2017 (Positive Committee)
 
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
 

Viewers also liked

2014 Epidemiological Update by Dr. Kathleen Brady
2014 Epidemiological Update by Dr. Kathleen Brady2014 Epidemiological Update by Dr. Kathleen Brady
2014 Epidemiological Update by Dr. Kathleen BradyOffice of HIV Planning
 
AACO's Client Services Unit (CSU) Update
AACO's Client Services Unit (CSU) UpdateAACO's Client Services Unit (CSU) Update
AACO's Client Services Unit (CSU) UpdateOffice of HIV Planning
 
Delaware County Social Determinants Sampler
Delaware County Social Determinants SamplerDelaware County Social Determinants Sampler
Delaware County Social Determinants SamplerOffice of HIV Planning
 
Youth Risk Behavior Survey Presentation, Antonio Boone
Youth Risk Behavior Survey Presentation, Antonio BooneYouth Risk Behavior Survey Presentation, Antonio Boone
Youth Risk Behavior Survey Presentation, Antonio BooneOffice of HIV Planning
 
Behavioral Health Navigator Presentation by Emerson Evans 12-12-13
Behavioral Health Navigator Presentation by Emerson Evans 12-12-13Behavioral Health Navigator Presentation by Emerson Evans 12-12-13
Behavioral Health Navigator Presentation by Emerson Evans 12-12-13Office of HIV Planning
 
Youth Risk Behavior Survey 2016 by Dr. Anne Frankel
Youth Risk Behavior Survey 2016 by Dr. Anne FrankelYouth Risk Behavior Survey 2016 by Dr. Anne Frankel
Youth Risk Behavior Survey 2016 by Dr. Anne FrankelOffice of HIV Planning
 
Integrated Planning Process Review, 2016
Integrated Planning Process Review, 2016Integrated Planning Process Review, 2016
Integrated Planning Process Review, 2016Office of HIV Planning
 

Viewers also liked (10)

2014 Epidemiological Update by Dr. Kathleen Brady
2014 Epidemiological Update by Dr. Kathleen Brady2014 Epidemiological Update by Dr. Kathleen Brady
2014 Epidemiological Update by Dr. Kathleen Brady
 
AACO's Client Services Unit (CSU) Update
AACO's Client Services Unit (CSU) UpdateAACO's Client Services Unit (CSU) Update
AACO's Client Services Unit (CSU) Update
 
Delaware County Social Determinants Sampler
Delaware County Social Determinants SamplerDelaware County Social Determinants Sampler
Delaware County Social Determinants Sampler
 
Youth Risk Behavior Survey Presentation, Antonio Boone
Youth Risk Behavior Survey Presentation, Antonio BooneYouth Risk Behavior Survey Presentation, Antonio Boone
Youth Risk Behavior Survey Presentation, Antonio Boone
 
Do 1 Thing - Dr. Stacey Trooskin
Do 1 Thing - Dr. Stacey TrooskinDo 1 Thing - Dr. Stacey Trooskin
Do 1 Thing - Dr. Stacey Trooskin
 
Behavioral Health Navigator Presentation by Emerson Evans 12-12-13
Behavioral Health Navigator Presentation by Emerson Evans 12-12-13Behavioral Health Navigator Presentation by Emerson Evans 12-12-13
Behavioral Health Navigator Presentation by Emerson Evans 12-12-13
 
Policy Briefing 02-14-13
Policy Briefing 02-14-13Policy Briefing 02-14-13
Policy Briefing 02-14-13
 
Youth Risk Behavior Survey 2016 by Dr. Anne Frankel
Youth Risk Behavior Survey 2016 by Dr. Anne FrankelYouth Risk Behavior Survey 2016 by Dr. Anne Frankel
Youth Risk Behavior Survey 2016 by Dr. Anne Frankel
 
Integrated Planning Process Review, 2016
Integrated Planning Process Review, 2016Integrated Planning Process Review, 2016
Integrated Planning Process Review, 2016
 
HIV Pre Exposure Prophylaxis
HIV Pre Exposure ProphylaxisHIV Pre Exposure Prophylaxis
HIV Pre Exposure Prophylaxis
 

Similar to The HIV Engagement in Care Cascade by Dr. Kathleen Brady

Dr. Kathleen Brady's 2013 Epidemiologic Update
Dr. Kathleen Brady's 2013 Epidemiologic UpdateDr. Kathleen Brady's 2013 Epidemiologic Update
Dr. Kathleen Brady's 2013 Epidemiologic UpdateOffice of HIV Planning
 
HIV Epidemiology in the Prairies
HIV Epidemiology in the PrairiesHIV Epidemiology in the Prairies
HIV Epidemiology in the Prairiesgriehl
 
Annual Epidemiological Presentation, 2017 - Kathleen Brady, PDPH
Annual Epidemiological Presentation, 2017 - Kathleen Brady, PDPHAnnual Epidemiological Presentation, 2017 - Kathleen Brady, PDPH
Annual Epidemiological Presentation, 2017 - Kathleen Brady, PDPHOffice of HIV Planning
 
Patient safety disparities presentation from 2015 CDC National Conference on ...
Patient safety disparities presentation from 2015 CDC National Conference on ...Patient safety disparities presentation from 2015 CDC National Conference on ...
Patient safety disparities presentation from 2015 CDC National Conference on ...Noel Eldridge
 
A Post-Census Mortality Survey to Capture HIV/AIDS Deaths
A Post-Census Mortality Survey to Capture HIV/AIDS Deaths A Post-Census Mortality Survey to Capture HIV/AIDS Deaths
A Post-Census Mortality Survey to Capture HIV/AIDS Deaths MEASURE Evaluation
 
A Post-Census Mortality Survey to Capture HIV/AIDS Deaths
A Post-Census Mortality Survey to Capture HIV/AIDS Deaths A Post-Census Mortality Survey to Capture HIV/AIDS Deaths
A Post-Census Mortality Survey to Capture HIV/AIDS Deaths MEASURE Evaluation
 
CSTE Conference_2015_Poster_Histoplasmosis_Fialkowski_Final
CSTE Conference_2015_Poster_Histoplasmosis_Fialkowski_FinalCSTE Conference_2015_Poster_Histoplasmosis_Fialkowski_Final
CSTE Conference_2015_Poster_Histoplasmosis_Fialkowski_FinalVeronica Fialkowski
 
HIV in men-who-have-sex-with-men(MSM)in the UK:predicted effectiveness and co...
HIV in men-who-have-sex-with-men(MSM)in the UK:predicted effectiveness and co...HIV in men-who-have-sex-with-men(MSM)in the UK:predicted effectiveness and co...
HIV in men-who-have-sex-with-men(MSM)in the UK:predicted effectiveness and co...cheweb1
 
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"HopkinsCFAR
 
Measuring the Vital Events in the Communities of Africa
Measuring the Vital Events in the Communities of AfricaMeasuring the Vital Events in the Communities of Africa
Measuring the Vital Events in the Communities of AfricaMEASURE Evaluation
 
A basic understanding of HIV surveillance
A basic understanding of HIV surveillanceA basic understanding of HIV surveillance
A basic understanding of HIV surveillanceDr.RAJEEV KASHYAP
 
HIV Epidemiology: Progress, challenges and Human Rights implications
HIV Epidemiology: Progress, challenges and Human Rights implications HIV Epidemiology: Progress, challenges and Human Rights implications
HIV Epidemiology: Progress, challenges and Human Rights implications Vih.org
 
HIV/Aids Surveillance Systems: Are They Implemented Effectively?
HIV/Aids Surveillance Systems: Are They Implemented Effectively? HIV/Aids Surveillance Systems: Are They Implemented Effectively?
HIV/Aids Surveillance Systems: Are They Implemented Effectively? Xiaoming Zeng
 
Global Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USAGlobal Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USAGlobal Medical Cures™
 
May 18 2011 Presentation: Part 1
May 18 2011 Presentation: Part 1May 18 2011 Presentation: Part 1
May 18 2011 Presentation: Part 1sumaorchard1
 

Similar to The HIV Engagement in Care Cascade by Dr. Kathleen Brady (20)

Dr. Kathleen Brady's 2013 Epidemiologic Update
Dr. Kathleen Brady's 2013 Epidemiologic UpdateDr. Kathleen Brady's 2013 Epidemiologic Update
Dr. Kathleen Brady's 2013 Epidemiologic Update
 
HIV Epidemiology in the Prairies
HIV Epidemiology in the PrairiesHIV Epidemiology in the Prairies
HIV Epidemiology in the Prairies
 
Annual Epidemiological Presentation, 2017 - Kathleen Brady, PDPH
Annual Epidemiological Presentation, 2017 - Kathleen Brady, PDPHAnnual Epidemiological Presentation, 2017 - Kathleen Brady, PDPH
Annual Epidemiological Presentation, 2017 - Kathleen Brady, PDPH
 
Wesat2105
Wesat2105Wesat2105
Wesat2105
 
Importance of HIV testing and linkage to care
Importance of HIV testing and linkage to careImportance of HIV testing and linkage to care
Importance of HIV testing and linkage to care
 
Patient safety disparities presentation from 2015 CDC National Conference on ...
Patient safety disparities presentation from 2015 CDC National Conference on ...Patient safety disparities presentation from 2015 CDC National Conference on ...
Patient safety disparities presentation from 2015 CDC National Conference on ...
 
A Post-Census Mortality Survey to Capture HIV/AIDS Deaths
A Post-Census Mortality Survey to Capture HIV/AIDS Deaths A Post-Census Mortality Survey to Capture HIV/AIDS Deaths
A Post-Census Mortality Survey to Capture HIV/AIDS Deaths
 
A Post-Census Mortality Survey to Capture HIV/AIDS Deaths
A Post-Census Mortality Survey to Capture HIV/AIDS Deaths A Post-Census Mortality Survey to Capture HIV/AIDS Deaths
A Post-Census Mortality Survey to Capture HIV/AIDS Deaths
 
CSTE Conference_2015_Poster_Histoplasmosis_Fialkowski_Final
CSTE Conference_2015_Poster_Histoplasmosis_Fialkowski_FinalCSTE Conference_2015_Poster_Histoplasmosis_Fialkowski_Final
CSTE Conference_2015_Poster_Histoplasmosis_Fialkowski_Final
 
HIV in men-who-have-sex-with-men(MSM)in the UK:predicted effectiveness and co...
HIV in men-who-have-sex-with-men(MSM)in the UK:predicted effectiveness and co...HIV in men-who-have-sex-with-men(MSM)in the UK:predicted effectiveness and co...
HIV in men-who-have-sex-with-men(MSM)in the UK:predicted effectiveness and co...
 
2016HIV_STI_SurveillanceReport
2016HIV_STI_SurveillanceReport2016HIV_STI_SurveillanceReport
2016HIV_STI_SurveillanceReport
 
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
 
Measuring the Vital Events in the Communities of Africa
Measuring the Vital Events in the Communities of AfricaMeasuring the Vital Events in the Communities of Africa
Measuring the Vital Events in the Communities of Africa
 
A basic understanding of HIV surveillance
A basic understanding of HIV surveillanceA basic understanding of HIV surveillance
A basic understanding of HIV surveillance
 
HIV Epidemiology: Progress, challenges and Human Rights implications
HIV Epidemiology: Progress, challenges and Human Rights implications HIV Epidemiology: Progress, challenges and Human Rights implications
HIV Epidemiology: Progress, challenges and Human Rights implications
 
HIV/Aids Surveillance Systems: Are They Implemented Effectively?
HIV/Aids Surveillance Systems: Are They Implemented Effectively? HIV/Aids Surveillance Systems: Are They Implemented Effectively?
HIV/Aids Surveillance Systems: Are They Implemented Effectively?
 
HIVScreeningApproved
HIVScreeningApprovedHIVScreeningApproved
HIVScreeningApproved
 
Anal Cytology and Anal Cancer Screening in HIV Patients
Anal Cytology and Anal Cancer Screening in HIV PatientsAnal Cytology and Anal Cancer Screening in HIV Patients
Anal Cytology and Anal Cancer Screening in HIV Patients
 
Global Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USAGlobal Medical Cures™ | HIV TESTING IN USA
Global Medical Cures™ | HIV TESTING IN USA
 
May 18 2011 Presentation: Part 1
May 18 2011 Presentation: Part 1May 18 2011 Presentation: Part 1
May 18 2011 Presentation: Part 1
 

More from Office of HIV Planning

Overview of the 2018 Update to the Integrated Plan and PrEP Workgroup Draft R...
Overview of the 2018 Update to the Integrated Plan and PrEP Workgroup Draft R...Overview of the 2018 Update to the Integrated Plan and PrEP Workgroup Draft R...
Overview of the 2018 Update to the Integrated Plan and PrEP Workgroup Draft R...Office of HIV Planning
 
Quality Management in the Philadelphia EMA
Quality Management in the Philadelphia EMAQuality Management in the Philadelphia EMA
Quality Management in the Philadelphia EMAOffice of HIV Planning
 
C-YA! Philadelphia EMA's Plan to Connect our Co-infected Community to a Cure ...
C-YA! Philadelphia EMA's Plan to Connect our Co-infected Community to a Cure ...C-YA! Philadelphia EMA's Plan to Connect our Co-infected Community to a Cure ...
C-YA! Philadelphia EMA's Plan to Connect our Co-infected Community to a Cure ...Office of HIV Planning
 
Epidemiology Update: Disparities in the HIV Continuum of Care
Epidemiology Update: Disparities in the HIV Continuum of CareEpidemiology Update: Disparities in the HIV Continuum of Care
Epidemiology Update: Disparities in the HIV Continuum of CareOffice of HIV Planning
 
Increasing Treatment Access and Saving Lives in the Dual Opioid and Overdose ...
Increasing Treatment Access and Saving Lives in the Dual Opioid and Overdose ...Increasing Treatment Access and Saving Lives in the Dual Opioid and Overdose ...
Increasing Treatment Access and Saving Lives in the Dual Opioid and Overdose ...Office of HIV Planning
 
Philadelphia National HIV Behavioral Surveillance, 2018
Philadelphia National HIV Behavioral Surveillance, 2018Philadelphia National HIV Behavioral Surveillance, 2018
Philadelphia National HIV Behavioral Surveillance, 2018Office of HIV Planning
 
Being Trauma-Informed in the Care of People Living with HIV
Being Trauma-Informed in the Care of People Living with HIVBeing Trauma-Informed in the Care of People Living with HIV
Being Trauma-Informed in the Care of People Living with HIVOffice of HIV Planning
 
Integrated HIV Surveillance and Prevention Programs for Health Departments - ...
Integrated HIV Surveillance and Prevention Programs for Health Departments - ...Integrated HIV Surveillance and Prevention Programs for Health Departments - ...
Integrated HIV Surveillance and Prevention Programs for Health Departments - ...Office of HIV Planning
 
Future Directions In Medical Case Management
Future Directions In Medical Case ManagementFuture Directions In Medical Case Management
Future Directions In Medical Case ManagementOffice of HIV Planning
 
Opioid Awareness - Report Review: The Mayor's Task Force to Combat the Opioid...
Opioid Awareness - Report Review: The Mayor's Task Force to Combat the Opioid...Opioid Awareness - Report Review: The Mayor's Task Force to Combat the Opioid...
Opioid Awareness - Report Review: The Mayor's Task Force to Combat the Opioid...Office of HIV Planning
 
Treatment Update - Modernizing the HIV Care Delivery Model
Treatment Update - Modernizing the HIV Care Delivery ModelTreatment Update - Modernizing the HIV Care Delivery Model
Treatment Update - Modernizing the HIV Care Delivery ModelOffice of HIV Planning
 

More from Office of HIV Planning (20)

Overview of the 2018 Update to the Integrated Plan and PrEP Workgroup Draft R...
Overview of the 2018 Update to the Integrated Plan and PrEP Workgroup Draft R...Overview of the 2018 Update to the Integrated Plan and PrEP Workgroup Draft R...
Overview of the 2018 Update to the Integrated Plan and PrEP Workgroup Draft R...
 
PrEP Update: CROI 2018
PrEP Update: CROI 2018PrEP Update: CROI 2018
PrEP Update: CROI 2018
 
Quality Management in the Philadelphia EMA
Quality Management in the Philadelphia EMAQuality Management in the Philadelphia EMA
Quality Management in the Philadelphia EMA
 
C-YA! Philadelphia EMA's Plan to Connect our Co-infected Community to a Cure ...
C-YA! Philadelphia EMA's Plan to Connect our Co-infected Community to a Cure ...C-YA! Philadelphia EMA's Plan to Connect our Co-infected Community to a Cure ...
C-YA! Philadelphia EMA's Plan to Connect our Co-infected Community to a Cure ...
 
Client Services Unit Update 2018
Client Services Unit Update 2018Client Services Unit Update 2018
Client Services Unit Update 2018
 
Epidemiologic Profile Preview
Epidemiologic Profile PreviewEpidemiologic Profile Preview
Epidemiologic Profile Preview
 
Epidemiology Update: Disparities in the HIV Continuum of Care
Epidemiology Update: Disparities in the HIV Continuum of CareEpidemiology Update: Disparities in the HIV Continuum of Care
Epidemiology Update: Disparities in the HIV Continuum of Care
 
Increasing Treatment Access and Saving Lives in the Dual Opioid and Overdose ...
Increasing Treatment Access and Saving Lives in the Dual Opioid and Overdose ...Increasing Treatment Access and Saving Lives in the Dual Opioid and Overdose ...
Increasing Treatment Access and Saving Lives in the Dual Opioid and Overdose ...
 
Philadelphia National HIV Behavioral Surveillance, 2018
Philadelphia National HIV Behavioral Surveillance, 2018Philadelphia National HIV Behavioral Surveillance, 2018
Philadelphia National HIV Behavioral Surveillance, 2018
 
Safer Consumption Spaces
Safer Consumption SpacesSafer Consumption Spaces
Safer Consumption Spaces
 
Philadelphia PrEP Working Group
Philadelphia PrEP Working GroupPhiladelphia PrEP Working Group
Philadelphia PrEP Working Group
 
Opioid Awareness
Opioid AwarenessOpioid Awareness
Opioid Awareness
 
Being Trauma-Informed in the Care of People Living with HIV
Being Trauma-Informed in the Care of People Living with HIVBeing Trauma-Informed in the Care of People Living with HIV
Being Trauma-Informed in the Care of People Living with HIV
 
Prevention Continuum
Prevention ContinuumPrevention Continuum
Prevention Continuum
 
Integrated HIV Surveillance and Prevention Programs for Health Departments - ...
Integrated HIV Surveillance and Prevention Programs for Health Departments - ...Integrated HIV Surveillance and Prevention Programs for Health Departments - ...
Integrated HIV Surveillance and Prevention Programs for Health Departments - ...
 
BenePhilly Programs Presentation
BenePhilly Programs PresentationBenePhilly Programs Presentation
BenePhilly Programs Presentation
 
Future Directions In Medical Case Management
Future Directions In Medical Case ManagementFuture Directions In Medical Case Management
Future Directions In Medical Case Management
 
Opioid Awareness - Report Review: The Mayor's Task Force to Combat the Opioid...
Opioid Awareness - Report Review: The Mayor's Task Force to Combat the Opioid...Opioid Awareness - Report Review: The Mayor's Task Force to Combat the Opioid...
Opioid Awareness - Report Review: The Mayor's Task Force to Combat the Opioid...
 
Treatment Update - Modernizing the HIV Care Delivery Model
Treatment Update - Modernizing the HIV Care Delivery ModelTreatment Update - Modernizing the HIV Care Delivery Model
Treatment Update - Modernizing the HIV Care Delivery Model
 
What is Integrated Planning?
What is Integrated Planning?What is Integrated Planning?
What is Integrated Planning?
 

Recently uploaded

Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls ServiceKesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Servicemakika9823
 
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...CALL GIRLS
 
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort ServiceCollege Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort ServiceNehru place Escorts
 
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service CoimbatoreCall Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatorenarwatsonia7
 
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service MumbaiLow Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbaisonalikaur4
 
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowSonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowRiya Pathan
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableNehru place Escorts
 
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...narwatsonia7
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...Miss joya
 
Call Girl Surat Madhuri 7001305949 Independent Escort Service Surat
Call Girl Surat Madhuri 7001305949 Independent Escort Service SuratCall Girl Surat Madhuri 7001305949 Independent Escort Service Surat
Call Girl Surat Madhuri 7001305949 Independent Escort Service Suratnarwatsonia7
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliRewAs ALI
 
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000aliya bhat
 
Call Girl Indore Vrinda 9907093804 Independent Escort Service Indore
Call Girl Indore Vrinda 9907093804 Independent Escort Service IndoreCall Girl Indore Vrinda 9907093804 Independent Escort Service Indore
Call Girl Indore Vrinda 9907093804 Independent Escort Service IndoreRiya Pathan
 
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original PhotosCall Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photosnarwatsonia7
 
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...narwatsonia7
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...Garima Khatri
 

Recently uploaded (20)

Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
 
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Servicesauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
 
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls ServiceKesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
 
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
Call Girls Service Surat Samaira ❤️🍑 8250192130 👄 Independent Escort Service ...
 
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCREscort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
 
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
 
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort ServiceCollege Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
College Call Girls Vyasarpadi Whatsapp 7001305949 Independent Escort Service
 
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service CoimbatoreCall Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
 
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service MumbaiLow Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
Low Rate Call Girls Mumbai Suman 9910780858 Independent Escort Service Mumbai
 
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowSonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
 
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls AvailableVip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
Vip Call Girls Anna Salai Chennai 👉 8250192130 ❣️💯 Top Class Girls Available
 
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Kanakapura Road Just Call 7001305949 Top Class Call Girl Service A...
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
 
Call Girl Surat Madhuri 7001305949 Independent Escort Service Surat
Call Girl Surat Madhuri 7001305949 Independent Escort Service SuratCall Girl Surat Madhuri 7001305949 Independent Escort Service Surat
Call Girl Surat Madhuri 7001305949 Independent Escort Service Surat
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas Ali
 
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
 
Call Girl Indore Vrinda 9907093804 Independent Escort Service Indore
Call Girl Indore Vrinda 9907093804 Independent Escort Service IndoreCall Girl Indore Vrinda 9907093804 Independent Escort Service Indore
Call Girl Indore Vrinda 9907093804 Independent Escort Service Indore
 
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original PhotosCall Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
Call Girl Service Bidadi - For 7001305949 Cheap & Best with original Photos
 
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
 

The HIV Engagement in Care Cascade by Dr. Kathleen Brady

  • 1. K A T H L E E N A . B R A D Y , M D M E D I C A L D I R E C T O R / M E D I C A L E P I D E M I O L O G I S T A I D S A C T I V I T I E S C O O R D I N A T I N G O F F I C E J A N U A R Y 9 , 2 0 1 3 The HIV Engagement in Care Cascade
  • 4. Gardner Stage of Engagement in HIV Care
  • 5. Gardner Stage of Engagement in HIV Care 19% undetectable
  • 6. National and Local Engagement in Care  Data  National and local HIV Surveillance System  Prevalence (total, diagnosed) – number of persons living with HIV  Linkage to care  Medical Monitoring Project (MMP)  Retention in care  Prescribed ART  Viral suppression
  • 7. Methods  Prevalence  HIV diagnosis data  Data adjustments at the national level  Back-calculation methods to estimate unaware  Linkage to Care  Data reported through December 2011  Percentage of persons with >1 CD4 or viral load test result within 3 months of HIV diagnosis
  • 8. Medical Monitoring Project  MMP is a national probability sample of HIV-infected persons receiving care in the US in order to:  describe HIV care and support services being received and the quality of such services  describe the prevalence and occurrence of co-morbidities related to HIV disease  determine prevalence of ongoing risk behaviors and access to and use of prevention services among persons living with HIV  identify met and unmet needs for HIV care and prevention services in order to inform community and care planning groups, health care providers and other stakeholders  Philadelphia has participated in MMP since 2005. All charts of sampled patients are abstracted for clinical information and patients are offered a voluntary interview.
  • 9. MMP Population Size Estimates  States, facilities, and patients sampled with known probabilities  Analysis weights include:  Design weights  Inverse of the probability of selection  Extend inference from sample to reference population  Non-response adjustment  Extend inference from respondents to sample  Sum of weights estimates number of HIV-infected adults who received at least one medical visit January-April 2009
  • 10. MMP Definitions  Retention in care: Number of HIV-infected adults who received at least one medical care visit between January and April 2009  Prescription of antiretroviral therapy (ART): Documentation in medical record abstraction of any ART prescription in the past 12 months  Viral suppression: Documentation in medical record abstraction of most
  • 11.
  • 12. Philadelphia Engagement in Care, 2009 19188 100% 15753 82% 11894 62% 9944 52% 8751 46% 5775 30% 0 5000 10000 15000 20000 25000
  • 13. For every 100 people living with HIV: US Number 82 Are aware of their infection 66 Are linked to HIV care 37 Stay in HIV care 33 Get antiretroviral therapy 25 Have a very low amount of virus in their body Philadelphia Number 82 Are aware of their infection 62 Are linked to HIV care 52 Stay in HIV care 46 Get antiretroviral therapy 30 Have a very low amount of virus in their body 2009 Data
  • 15. Philadelphia Engagement in Care, 2009 19188 100% 15753 82% 11894 62% 9944 52% 8751 46% 5775 30% 0 5000 10000 15000 20000 25000
  • 16.
  • 17.
  • 18. HIV Prevalence in Philadelphia (reported thru 6/30/2012)  19,157 PLWHA (aware)  11,583 AIDS cases  7,574 HIV cases  5,092 estimated to be living with HIV and unaware  1.59% Philadelphia residents estimated to be HIV+  Rates (known) vary by race  2.1% of blacks  1.5% of Latinos  0.7% of whites  Rates vary by sex  1.9% of males  0.7% of females
  • 19. 19 HIV/AIDS Cases by Date of Diagnosis 1178 1302 1177 1001 898 1200 894 895 907 861 821 712 756 652 452 221 239 176 940 918 921 893 729 712 1308 0 200 400 600 800 1000 1200 1400 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 Year NumberofCases AIDS HIV
  • 20. 20 HIV/AIDS Cases by Sex and Date of Diagnosis 0 200 400 600 800 1000 1200 1400 1600 1991 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 Year NumberofCases AIDS Female AIDS Male HIV Female HIV Male
  • 21. 21 HIV Cases by Race/Ethnicity and Date of Diagnosis 171 142 127 106 110 575 594 534 479 498 133 146 210 127 95 0 100 200 300 400 500 600 700 2006 2007 2008 2009 2010 2011 Year NumberofCases White AfrAm Hispanic
  • 22. HIV diagnoses by risk group, 2007-2011 0 100 200 300 400 500 600 2007 2008 2009 2010 2011 MSM IDU HET
  • 23. Demographics of new positives, MSM New HIV diagnoses among MSM by race, 2007-2011 0% 10% 20% 30% 40% 50% 60% 70% Black Latino White New HIV diagnoses among MSM by age, 2007-2011 0% 10% 20% 30% 40% 50% 60% 13 - 24 25 - 44 45+
  • 24. New HIV diagnoses among MSM youth, 2007-2011 New HIV diagnoses among MSM youth, 2007-2011 75.4% 9.3% 12.6% Race Black White Latino 7.6% 92.0% Age 13-17 18-24 Demographics of new positives, MSM youth
  • 25.
  • 26.
  • 27. New HIV diagnoses among IDU, 2007-2011 New HIV diagnoses among IDU, 2007-2011 44.1% 38.0% 16.0% Race Black White Latino 10.2% 53.1% 36.2% Age 13-24 25-44 45+ Demographics of new positives, IDU
  • 28. Demographics of new positives, IDU 2007 - 2011 70.1% 29.8% Sex Male Female
  • 29.
  • 30. New HIV diagnoses among HET, 2007-2011 New HIV diagnoses among HET, 2007-2011 72.7% 15.0% 8.8% Race Black White Latino 3.8% 50.6% 34.6% Age 13-24 25-44 45+ Demographics of new positives, Heterosexuals
  • 31. Demographics of new positives, HET 2007 - 2011 50.7% 49.2% Sex Male Female
  • 32.
  • 33.
  • 34.
  • 35. 35 Summary  High HIV morbidity in Philadelphia  Philadelphia epidemic predominantly affects minority populations  MSM and Heterosexual transmission predominant modes of transmission  Cases among MSM are increasing  Growing numbers of persons living with HIV and AIDS  25% decline in newly diagnosed AIDS
  • 36. Who is getting infected?
  • 37. Philadelphia Engagement in Care, 2009 19188 100% 15753 82% 11894 62% 9944 52% 8751 46% 5775 30% 0 5000 10000 15000 20000 25000
  • 38. Incidence Surveillance  Collect and STARHS test the diagnostic blood specimens from all newly diagnosed HIV infections reported from public and private laboratories and providers to HIV Surveillance Unit.  Collect the HIV testing information needed for the statistical estimates of incidence.  Calculate population-based estimates of HIV incidence.  Use these estimates to identify emerging sub- epidemics, monitor trends, target prevention resources and interventions to areas and populations most heavily affected, and evaluate programs.
  • 39. Incidence vs. Prevalence HIV Prevalence = the total number of HIV cases that exist at a specific time within a specific population. HIV Incidence = the number of individuals newly infected with HIV within a given period of time (6 - 12 months). 20061981 2007 20061981 2007
  • 41. Remnant HIV+ Serum Supplemental Data STARHS Testing using BED Assay Includes: •Race, sex, mode of transmission •Testing history & reasons for testing (Calculating weights) •Any exclusionary info (AIDS diagnosis, prior recent ART) •Adjust for LFU, QNS HIV Incidence Estimation Requirements for HIV Incidence Surveillance
  • 42. CDC STARHS Test Results  (+) standard test and (+) STARHS test = long-standing HIV infection  (+) standard test and (-) STARHS test = recent HIV infection
  • 43. National Incidence Data, 2010  Estimated 47,500 HIV infections in 2009 in adults and adolescents (95% CI, 42,000 – 53,000)  Estimated incidence 18.8 infections per 100,000 population  44% among blacks, 21% Latinos  63% among MSM, 25% heterosexual  26% among 13-24 year olds  Early signs of an encouraging decrease in new HIV infections among black women  21 percent decrease between 2008 and 2010  Continuing increase in new infections among young gay and bisexual men  22 percent increase between 2008 and 2010
  • 44. 2010 Local Estimate of HIV Incidence  Local estimate of 577 new HIV infections in 2010 in adults and adolescents (95% CI, 385-769)  2010 estimate is significantly lower than the estimate from 2008 (926 infections) and 2009 (945 infections)  Case rate of 45.1 infections per 100,000 population (2.4 times that of the national rate)  The estimated decline in incidence must be interpreted with caution due to violations in the estimation assumptions
  • 45. HIV Incidence Trends by Demographic Groups 0 200 400 600 800 1000 2006 2007 2008 2009 2010 Total Age 13-24 Male Black MSM
  • 46. HIV Incidence Trends by Demographic Groups 0 200 400 600 800 1000 2006 2010 Total Age 13-24 Male Black MSM
  • 47. Estimated Incidence Rates - 2010 Population Population in 2010 (13 +) ESTIMATED Incidence Estimate, 20010 Estimated Case Rate per 100,000 95% CI lower bound 95% CI upper bound MSM 29,737 306 1,029.0 578.4 1,483.0 IDU 37,378 44 117.7 0.0 254.2 HET 294,682 226 76.7 30.1 60.1 *Includes persons >13 living in poverty Data Source: PDPH/AACO HIV Incidence Surveillance Program
  • 48. Incidence Summary  Includes people unaware of their status.  40% decrease between 2009 and 2010  P<0.05  Declines in all demographic groups  Incidence higher than baseline 2006 data for MSM and youth 13-24
  • 50. Philadelphia Engagement in Care, 2009 19188 100% 15753 82% 11894 62% 9944 52% 8751 46% 5775 30% 0 5000 10000 15000 20000 25000
  • 53. National HIV Behavioral Surveillance  Risk Behaviors  Assess prevalence of and trends in risk behaviors  Sexual risk behaviors  Drug-use risk behaviors  HIV Testing Behaviors  Assess prevalence of and trends in HIV testing behaviors (not included until HET-1)
  • 54. NHBS Objectives (cont.)  Prevention  Assess exposure to and use of prevention services  Assess impact of prevention services on behavior  Identify prevention service gaps and missed opportunities for prevention
  • 55. NHBS-MSM3  Interviews conducted at venues where at least 50% of men identified as MSM  List of venues included in your attachments  566 MSM interviewed in Philadelphia  545 had sex with a man in the last 12 months  26.2% white, 57.6% black, 11.4% Latino  83.6% identified as gay, 14.6% bisexual, 1.9% as straight
  • 56. NHBS-MSM Summary  We are not currently meeting the PHS guidelines for HIV testing  76.8% of MSM ever tested  Less than half (46.9%) of MSM had tested in the last year  Lower prevalence of HIV in MSM seen in Philadelphia
  • 57. Philadelphia NHBS-MSM3, 2011 76.4% 76.2% 76.1% 78.5% NHBS-MSM3 % of MSM who had an HIV test in the last 12 months ALL MSM Black MSM LatinoMSM White MSM Demograp hic Group MSM3 % HIV Positive Tested = 519 MSM3 % New Positiv es Total 11.9% 29.0% Race Black 14.9% 31.8% White 8.5% 16.7% Latino 6.8% 50.0% Age 18-24 8.2% 50.0% 25-44 10.6% 35.1% 45+ 19.8% 21.1%
  • 58. NHBS-IDU2  539 IDU interviewed in Philadelphia  75.3% male, 24.7% female, 88.1% over 30  54.8% black, 42.8% white, 15% Latino  87.8% reported ever testing for HIV with 2.8% reporting being HIV+  38.6% reported having an HIV test within the last year  16.0% reported having an HIV test within the last 6 months  57.7% ever tested for Hepatitis C  52.1% told they had Hepatitis (95.0% Hep C)
  • 59. IDU2 Testing Data Demographic Group IDU2 % HIV Positive (Tested = 536) IDU2 % New Positives Total 8.9% 68.1% Gender Male 7.7% 70.0% Female 12.9% 64.7% Race Black 14.3% 65.7% White 2.6% 80.0% Latino 8.6% 71.4%
  • 60. IDU2 Testing Data Demographic Group IDU2 % HIV Positive (Tested = 536) IDU2 % New Positives Age Group 18-24 0.0% 0.0% 25-44 3.8% 66.7% 45+ 13.5% 60.5% Geographic Area Kensington 4.2% 66.6% NW 12.5% 100.0% North 8.6% 76.9% West 23.4% 55.5%
  • 61. What is a High-Risk Heterosexual?  Past definitions  Multiple sexual partners  Sexual partners’ risks  New definitions evaluated in NHBS-HET1  Geography (HIV is clustered in high-poverty neighborhoods)  Social networks (Some social and sexual networks have high HIV despite equal individual risks, greater inter- network mixing)
  • 62. HIV Prevalence NHBS-HET1 2006-2007 HIV Test Result Negative Positive Total 14,543 294 14,837 N (98) (2) (100) (%) 2% HIV prevalence is 10 to 20 times greater than that among all heterosexuals in the U.S.
  • 63. 10−19% 20−29% ≥ 40% Proportion of Census Tract Residents Living Below the Poverty Level 0−9% PercentHIV-positive 30−39% HIV Prevalence, by Census Tract Poverty NHBS-HET1 2006-2007 Chi-Square Trend, p< 0.0001
  • 64. 10−19,999 20−49,999 ≥ 50,000 Annual Household Income (in Dollars) 0−9,999 PercentHIV-positive HIV Prevalence, by Income NHBS-HET1 2006-2007 Chi-Square Trend, p< 0.0001
  • 65. 10−19,999 20−49,999 ≥ 50,000 Annual Household Income (in Dollars) 0−9,999 PercentHIV-positive HIV Prevalence, by Income NHBS-HET1 2006-2007
  • 66. 10−19,999 20−49,999 ≥ 50,000 Annual Household Income (in Dollars) 0−9,999 PercentHIV-positive HIV Prevalence, by Income NHBS-HET1 2006-2007 6X Greater
  • 67. *Controlling for city, sex, race/ethnicity, age, education, employment, income, homeless status, crack use, exchange sex, and STD diagnosis. HIV Prevalence, Multivariable Model* NHBS-HET1 2006-2007 Low socioeconomic status was associated with higher HIV prevalence: • Low income • Limited education • Unemployment • Resident of city • Sex with an opposite-gender partner in the past year • English- or Spanish-speaking
  • 68. HIV Surveillance & Census Data 37 States with HIV Reporting 2007 Persons(inthousands) Heterosexuals Living with HIV African- American Latino White
  • 69. HIV Surveillance & Census Data 37 States with HIV Reporting 2007 Persons(inthousands) Heterosexuals Living with HIV African- American Latino White Persons(inmillions) Adult & Adolescent Population African- American Latino White
  • 70. Ratio of Heterosexuals Living with HIV to the Population– African-Americans: > 20 times greater Latinos: 6 times greater
  • 71. HIV Prevalence, by Race/Ethnicity NHBS-HET1 2006-2007 African- American Latino White PercentHIV-positive p= 0.14
  • 72. HIV Prevalence, by Race/Ethnicity NHBS-HET1 2006-2007 All Census Tracts African- American Latino White PercentHIV-positive African- American Latino White High Poverty Census Tracts PercentHIV-positive p= 0.14 p= 0.73
  • 73. HIV Prevalence, by Race/Ethnicity NHBS-HET1 2006-2007 All Census Tracts African- American Latino White PercentHIV-positive African- American Latino White High Poverty Census Tracts PercentHIV-positive p= 0.14 p= 0.73
  • 74. HIV Prevalence, by Race/Ethnicity NHBS-HET1 2006-2007 All Census Tracts African- American Latino White PercentHIV-positive African- American Latino White High Poverty Census Tracts PercentHIV-positive p= 0.14 p= 0.73
  • 75. Exchange Sex STD Diagnosis Crack Use PercentHIV-positive Yes No HIV Prevalence, by Risk Behavior NHBS-HET1 2006-2007 p< 0.0001 p< 0.0001p< 0.0001
  • 76. ● HIV prevalence was very high ● Low socioeconomic status was associated with higher HIV prevalence ● Racial and ethnic disparities in HIV prevalence were substantially less than those in the general population ● Crack use and exchange sex were not associated with higher HIV prevalence Summary
  • 77. NHBS-HET2 Methods  RDS method chosen for NHBS-HET2  Eligibility Criteria  Between the ages of 18-60  Male or female  Had vaginal or anal sex with a person of the opposite-sex in the past 12 months  Lives in the EMA  Able to complete the interview in English or Spanish
  • 78. NHBS-HET2 Data  617 HET screened in Philadelphia  552 HET interviewed  510 met the HET definition  42.5% male, 57.5% female  25.3% 18-24  84.3% black, 2.2% white, 12.4% Latino, 1.2% other  94.9% had never injected drugs, 5.1% past IDU  15.9% currently or previously homeless
  • 79. NHBS-HET2 data  Education  34.5% less than high school education  54.5% high school education  10.0% with vocational/tech or some college  1.0% college graduate  Poverty  10.6% above poverty guideline  87.6% at or below poverty
  • 80. HET2 Demographics  HIV Testing  76.3% reported ever testing for HIV with 2.8% reporting being HIV+  20.3% reported having an HIV test within the last 6 months  28.4% reported having an HIV test within the last year
  • 81. HET2 Testing Data Tested # HIV Positive % New Positive All Participants 4.4% (N=24) 79.2% Low SES 4.5% (N=23) Not Low SES 2.8% (N=1) Male 5.9% (N=13) Female 3.4% (N=10) Black 5.1% (N=22) Latino 1.6% (N=1) White 0.0% (N=0)
  • 82. HET2 Testing Data Demographic Group HET2 % HIV Positive (Tested = 552) HET2 % New Positives All Participants 4.3% 79.2% Gender Male 5.4% 84.6% Female 3.6% 72.7% Race/Ethnicity Black 5.0% 78.3% Latino 1.4% 100.0% White 0.0% 0.0%
  • 83. HET2 Testing Data Demographic Group HET2 % HIV Positive (Tested = 552) HET2 % New Positives Age 18-24 1.5% 50.0% 25-44 3.5% 75.0% 45+ 7.4% 85.7% Low SES 3.4% 84.2% Not Low SES 0.9% 60.0%
  • 85. Philadelphia Engagement in Care, 2009 19188 100% 15753 82% 11894 62% 9944 52% 8751 46% 5775 30% 0 5000 10000 15000 20000 25000
  • 86. Linkage to Care 2009-2010 by Age, Race 74% 68% 73% 79% 75% 76% 72% 76% 81% 60% 65% 70% 75% 80% 85% Total 13-24 25-34 35-44 45-54 55+ Black Hispanic White
  • 87. Linkage to Care 2009-2010 by Sex, Mode 74% 68% 73% 72% 74% 75% 43% 69% 81% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% Total Male Female MSM Male IDU Male HET Male MSM/IDU Female IDU Female HET
  • 89. Philadelphia Engagement in Care, 2009 19188 100% 15753 82% 11894 62% 9944 52% 8751 46% 5775 30% 0 5000 10000 15000 20000 25000
  • 90. Definition: Met Need for Primary Care  Met Need for Primary Care defined as measurement of at least one CD4 count and/or one Viral Load and/or receipt of antiretroviral therapy during a specified time period
  • 91. Framework  Input  Population sizes of those with HIV and AIDS within the service area  Care Patterns of those with HIV and AIDS  Calculated Result  Number of persons with HIV and AIDS with unmet need
  • 92. Population Sizes Value Data Source(s) Row A. Number of persons living with AIDS (PLWA), for the period of 12/31/2011 11,569 Local HARS data Row B. Number of persons living with HIV (PLWH)/non- AIDS/aware, for the period of 12/31/2011 7,523 Local HARS data Row C. Total number of HIV+/aware for the period of 12/31/2011 19,092 Local HARS data Population Sizes
  • 93. Care Patterns Value Data Source(s) Row D. Number of PLWA who received the specified HIV primary medical care during the 12- month period of 2011 9,948 Surveillance Data (Lab Data) CAREWare Row E. Number of PLWH/non-AIDS who received the specified HIV primary medical care during the 12- month period of 2011 5,132 Surveillance Data (Lab Data) CAREWare
  • 94. Row F. Total number of HIV+/aware who received the specified HIV primary medical care during the 12-month period of 2011 15,080
  • 95. Calculated Results Value Calculation Row G. Number of PLWA who did not receive primary medical services during the 12-month period of 2011 1,621 (14.0%) = A – D Row H. Number of PLWH/non- AIDS who did not receive primary medical services during the 12-month period of 2011 2,391 (31.8%) = B – E Row I. Total of HIV+/aware not receiving specified primary medical care services (quantified estimate of unmet need 4,012 (21.0%) = G + H
  • 96. Unmet need by demographic groups, 2011 33.6% 13.4% 27.4% 15.5% 31.8% 15.2% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% 40.0% HIV AIDS Black White Hispanic 33.4% 15.2% 28.1% 10.6% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% 40.0% HIV AIDS Male Female
  • 97. Unmet need by insurance status, 2011 28.3% 13.5% 22.4% 12.6% 33.7% 7.5% 46.4% 29.6% 43.1% 26.6% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% 40.0% 45.0% 50.0% HIV AIDS Medicaid Private Other public Unknown None
  • 99. Philadelphia Engagement in Care, 2009 19188 100% 15753 82% 11894 62% 9944 52% 8751 46% 5775 30% 0 5000 10000 15000 20000 25000
  • 100.
  • 101. Engagement in Care by Sex, 2009 0 2000 4000 6000 8000 10000 12000 Male 0 1000 2000 3000 4000 5000 6000 Female
  • 102.
  • 103. Engagement in Care by Race/Ethnicity, 2009 0 2000 4000 6000 8000 10000 12000 Diagnosed In Care On ART Suppressed Black White Hispanic
  • 104.
  • 105. Engagement in Care by Mode of Transmission, 2009 0 1000 2000 3000 4000 5000 6000 Diagnosed In Care On ART Suppressed MSM HET male HET female
  • 106.
  • 107. Engagement in Care by Age Group, 2009 0 1000 2000 3000 4000 5000 6000 Diagnosed In Care On ART Suppressed 18-24 25-34 35-44 45-54 55+
  • 108. Engagement in Care Summary  On ART  Higher for males than females  Higher for men who have sex with men (MSM) than for women who have sex with men (WSM)  Viral suppression  Higher for males than females  Higher for MSM than WSM  Higher for whites compared to blacks and Hispanics  Higher for those >50 compared to 18-29 year olds All P values <0.05
  • 109. clinicaloptions.com/hiv Starting Antiretroviral Therapy in 2012: A Compendium of Interactive Cases What Will It Take to Substantially Reduce HIV Transmission in an Entire Population? •Answer: Treatment AND Prevention •Gardner EM, et al. Clin Infect Dis. 2011;52:793-800. •200,000 •600,000 •0 •800,000 •1,000,000 •1,200,000 •400,000 •19% •22% •34% •28% •21% •66% •NumberofIndividuals •Current •DX 90% •Engage 90% •Treat 90% •VL < 50 in 90% •Dx, Engage, Tx, and VL < 50 in 90% Undiagnosed HIV Not linked to care Not retained in care ART not required ART not utilized Viremic on ART Undetectable HIV-1 RNA
  • 110. Q U E S T I O N S ? The End